| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/23/2008 | CN100404068C Injection solution comprising an LHRH antagonist |
| 07/23/2008 | CN100404039C Safflower medicine composition and its preparation process and use |
| 07/23/2008 | CN100404032C Novel crystalline forms of the anti-cancer compound ZD1839 |
| 07/23/2008 | CN100404028C Novel use of Brazil Hematine red |
| 07/23/2008 | CN100404027C Carbamaid peroxide freeze dried formulation for injection, its preparation method and uses |
| 07/23/2008 | CN100404024C Synergestic combinations comprising renin inhibitor for cardiovascular diseases |
| 07/23/2008 | CN100404019C Multivesicular emulsion topical delivery systems |
| 07/23/2008 | CN100403932C Nutrition powder for increasing memory |
| 07/22/2008 | US7402688 novel 2,2-disubstituted-19-norvitamin D derivatives and 20-epi-19-norvitamin D derivatives; metabolic regulatory hormone of calcium and phosphorus; biological activities: cellular induced differentiation, suppression of proliferation, and immunomodulation by transcription control of target gene |
| 07/22/2008 | US7402606 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss |
| 07/22/2008 | US7402605 E.g., 17,17-propano-16-hydroxy-5-(4-ethoxycarbonylthiazol-2-yl)-9-oxo-1,2,3,4,20-pentanor-5-thia-8-azaprost-13-ene; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 07/22/2008 | US7402604 4-oxy- or amino-substituted indole-2-carboxy acids, esters and amides, e.g., N-(2-hydroxy-1-phenylethyl) 4-hydroxy-1-methyl-1H-indole-2-carboxamide; nicotinic receptor agonist; conditions associated with reductions in nicotinic transmission; Alzheimer's disease, anxiety or schizophrenia |
| 07/22/2008 | US7402603 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 07/22/2008 | US7402600 Nitroderivatives of cardiovascular agents |
| 07/22/2008 | US7402595 JNK inhibitor |
| 07/22/2008 | US7402590 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/22/2008 | US7402586 3-Benzylsulfonylamino-6-methyl-1-[(3-guanidinooxypropyl)aminocarbonylmethyl]-2-pyridinone trifluoroacetate; anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage |
| 07/22/2008 | US7402585 For example, 2-(3-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino}-1H-pyrazol-5-yl)-N-phenylacetamide; use in the treatment of certain diseases, in particular to proliferative disease such as cancer |
| 07/22/2008 | US7402583 Substituted quinolines as antitumor agents |
| 07/22/2008 | US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 07/22/2008 | US7402572 Suppressing a symptom of an allergic response using nucleic acids containing unmethylated CpG dinucleotides |
| 07/22/2008 | US7402571 Methods and pharmaceutical compositions for healing wounds |
| 07/22/2008 | US7402560 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/22/2008 | US7402557 Reducing epithelial toxicity such as a skin rash or diarrhea during cancer therapy, by coadministering KGF with erlotinib (N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazoline amine) |
| 07/22/2008 | US7402421 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 07/22/2008 | US7402324 Process for preparing aqueous extracts of plants and extracts so obtained |
| 07/22/2008 | US7402304 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders |
| 07/22/2008 | US7402299 Intracorporeal medicaments for photodynamic treatment of disease |
| 07/22/2008 | CA2481246C Compounds that modulate ppar activity and methods for their preparation |
| 07/22/2008 | CA2417825C 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 07/22/2008 | CA2388076C Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 07/22/2008 | CA2384418C Use of cytokines, cells, and mitogens to inhibit graft versus host disease |
| 07/22/2008 | CA2383011C Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 07/22/2008 | CA2366922C Formulations for detecting asthma |
| 07/22/2008 | CA2313638C Cyclohexene carboxylates as neuraminidase inhibitors |
| 07/22/2008 | CA2310748C Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
| 07/22/2008 | CA2283420C Lyme disease antigen compositions and uses |
| 07/22/2008 | CA2280773C Methods for the administration of amifostine |
| 07/22/2008 | CA2278223C 1,4-dihydropyridin derivatives and their use in therapy |
| 07/22/2008 | CA2265095C Pyrazolopyrimidines and pyrazolotriazines |
| 07/17/2008 | WO2008084872A1 Hydrazone derivative |
| 07/17/2008 | WO2008084864A1 Capsaicin receptor activator and apparatus for spraying the same |
| 07/17/2008 | WO2008084861A1 Condensed pyridine compound |
| 07/17/2008 | WO2008084828A1 Method for producing coenzyme q10 particle |
| 07/17/2008 | WO2008084762A1 Neurogenesis-promoting composition comprising theanine |
| 07/17/2008 | WO2008084710A1 Inhibitor of herpesvirus infection, method for inhibition of herpesvirus infection, and use thereof |
| 07/17/2008 | WO2008084574A1 Anti-angiogenic agent |
| 07/17/2008 | US20080171882 [(4S)-4-Methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride and [(4R)-4-methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride; chemical intermediates for enzyme inhibitors |
| 07/17/2008 | US20080171797 Contacting in vivo a mitochondrial NAD-dependent deacetylase polypeptide with test agent in assay mixture of NAD and an acetylated histone peptide; determining effect on the enzymatic activity of mitochondrial NAD-dependent deacetylase; drug screening; diagnosis; anticarcinogenic and antitumor agents |
| 07/17/2008 | US20080171783 Compositions and methods for treating hyperproliferative disease |
| 07/17/2008 | US20080171778 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/17/2008 | US20080171735 SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
| 07/17/2008 | US20080171732 e.g. ethyl6-{4-[(benzylsulfonyl)carbamoyl]piperidin-1-yl}-5-cyano-2-methoxynicotinate; reversible and selective purinergic receptor antagonist; anticoagulant; cardiovascular diseases; platelet aggregation, thrombotic occlusion, myocardial infarction and unstable angina |
| 07/17/2008 | US20080171730 Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes and vascular and renal disorders |
| 07/17/2008 | US20080171726 oxygen antagonists; reducing agent, preservatives; enhancing survivability and achieving stasis or pre-stasis in biological materials (cells, tissues); organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer |
| 07/17/2008 | US20080171715 Methods and compositions involving mirna and mirna inhibitor molecules |
| 07/17/2008 | US20080171714 Substances for preventing and treating autoimmune diseases |
| 07/17/2008 | US20080171705 Methods of inducing and treating vascular disease |
| 07/17/2008 | US20080171106 Exposing probiotic to a gastric juice; providing a model of a pet small intestine;introducing the probiotic and a pathogen into the model;measuring anti-pathogenic metabolite produced by probiotic; andusing the identified probiotic to produce a pet food |
| 07/17/2008 | US20080171060 Lymphocyte receptor peptide for use in prevention and treatment of viral infection, cell proliferative, cardiovascular and allergic disorders; enhancing cytokine production |
| 07/17/2008 | US20080171054 Immunoglobulin for use in detection, prevention and treatment of methicillin-resistant staphylococcus aureus (MRSA) infection |
| 07/17/2008 | US20080171052 Hmgb1 protein inhibitorsand/or antagonists for the treatment of vascular diseases |
| 07/17/2008 | US20080171050 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 07/17/2008 | US20080171042 Using antisense agents to prevent/reduce cell surface glycoprotein expression and treat cell proliferative disorders of prostate gland |
| 07/17/2008 | US20080171036 Using tumor necrosis factor specific immuoglobulin for diagnosis, treatment and prevention of inflammatory, cell proliferative, skin, respiratory system, nervous system and infectious disorders |
| 07/17/2008 | US20080171035 Mammalian cell membrane proteins; related reagents |
| 07/17/2008 | US20080171025 Using histidine and lysine (HK) as carrier sequences in small interfering RNA transfection complex; for use in prevention and treatment of cell proliferative, muscular, blood, respiratory and nervous system disorders |
| 07/17/2008 | US20080171023 Nutrient broth comprising nervous system tissue is exposed to tumor associated antigen in order to ellicit enhanced CD8+T cell response; administered to cancer patient to treat cell proliferative disorders; immunotherapy |
| 07/17/2008 | US20080171021 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 07/17/2008 | US20080170991 Selectively targeted antimicrobial peptides and the use thereof |
| 07/17/2008 | US20080170989 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules |
| 07/17/2008 | DE4393381B4 PTH-Verbindungen mit PTH-ähnlicher Aktivität, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und deren Verwendungen PTH compounds having PTH-like activity, to processes for their preparation, pharmaceutical compositions containing them and their uses |
| 07/17/2008 | CA2675288A1 Condensed pyridine compound |
| 07/16/2008 | EP1944307A2 Synthetic Salicylihalamides, Apicularens and Derivatives Thereof |
| 07/16/2008 | EP1944300A2 Prodrugs of aspartyl protease inhibitors |
| 07/16/2008 | EP1944292A1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 07/16/2008 | EP1944291A1 Optically active cyclic alcohol compound and method for producing same |
| 07/16/2008 | EP1944043A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 07/16/2008 | EP1944041A1 Therapeutic agent for neurogenic pain |
| 07/16/2008 | EP1944033A2 Use of pectin hydrolysis products |
| 07/16/2008 | EP1944027A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same |
| 07/16/2008 | EP1944026A2 Use of EDG receptor binding agents in cancer |
| 07/16/2008 | EP1944024A1 O-substituted aniline derivative and antioxidant drug |
| 07/16/2008 | EP1944021A1 Equol level regulator |
| 07/16/2008 | EP1635837B1 (3-((quinazolin-4-yl)amino)-1h-pyrazol-1-yl)acetamide derivatives and related compounds as aurora kinase inhibitors for the treatment of proliferative diseases such as cancer |
| 07/16/2008 | EP1506205B1 Novel azacyclic ethynyl derivatives |
| 07/16/2008 | EP1485160B1 Intraductal management of breast lesions involving therapeutic or diagnostic agents |
| 07/16/2008 | EP1476541B1 Cytokine (zcytor17 ligand) |
| 07/16/2008 | EP1476151B1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders |
| 07/16/2008 | EP1471907B1 Use of c-kit inhibitors for treating autoimmune diseases |
| 07/16/2008 | EP1392655B1 Potassium channel openers |
| 07/16/2008 | EP1392264B1 Delivery of antiemetics through an inhalation route |
| 07/16/2008 | EP1392257B1 Delivery of antihistamines through an inhalation route |
| 07/16/2008 | EP1390372B1 1-oxa-3,9-diaza-spiro'5,5]undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 07/16/2008 | EP1294367B1 Oral compositions comprising host-response modulating agent |
| 07/16/2008 | EP1265603B1 Il-8 receptor antagonists |
| 07/16/2008 | EP1200108B1 Use of ginkgo extract for treating cancer which is characterized by an over-expression of peripheral-type benzodiazepine receptor protein |
| 07/16/2008 | CN101223160A Benzoimidazole compound capable of inhibiting prostaglandin D synthetase |
| 07/16/2008 | CN101223134A Derivatives of seleno-amino acids |
| 07/16/2008 | CN101220089A Chinese South China sea signal conus neurotoxin gene Lt3.1 and uses thereof |